Bentad, Lawrence S.
HRN: 21-93-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
09/24/2022
10/01/2022
IVT
2.5 Ml
12 Hrs
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes